Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avantor, Inc. (AVTR : NYSE)
 
 • Company Description   
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.

Number of Employees: 13,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.12 Daily Weekly Monthly
20 Day Moving Average: 10,207,231 shares
Shares Outstanding: 682.76 (millions)
Market Capitalization: $5,543.97 (millions)
Beta: 0.94
52 Week High: $15.93
52 Week Low: $7.27
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.64% -0.47%
12 Week -9.88% -16.69%
Year To Date -29.14% -36.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING ONE SUITE 200 100 MATSONFORD ROAD
-
RADNOR,PA 19087
USA		 ph: 610-386-1700
fax: -		 avantorir@avantorsciences.com http://www.avantorsciences.com
 
 • General Corporate Information   
Officers
Emmanuel Ligner - President and Chief Executive Officer
Greg Summe - Chairman of the Board of Directors
R. Brent Jones - Executive Vice President and Chief Financial Offic
Steven Eck - Senior Vice President and Chief Accounting Officer
Juan Andres - Director

Peer Information
Avantor, Inc. (CHCR)
Avantor, Inc. (ESRX)
Avantor, Inc. (MYDP)
Avantor, Inc. (COR)
Avantor, Inc. (GBCS)
Avantor, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 05352A100
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/07/26
Share - Related Items
Shares Outstanding: 682.76
Most Recent Split Date: (:1)
Beta: 0.94
Market Capitalization: $5,543.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.19 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.79 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 2.19% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 10.31
Trailing 12 Months: 9.55
PEG Ratio: 4.71
Price Ratios
Price/Book: 0.99
Price/Cash Flow: 5.36
Price / Sales: 0.85
EPS Growth
vs. Year Ago Period: -26.09%
vs. Previous Quarter: -22.73%
Sales Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -4.94%
ROE
03/31/26 - 9.95
12/31/25 - 10.45
09/30/25 - 10.91
ROA
03/31/26 - 4.78
12/31/25 - 5.06
09/30/25 - 5.34
Current Ratio
03/31/26 - 1.76
12/31/25 - 1.78
09/30/25 - 1.49
Quick Ratio
03/31/26 - 1.17
12/31/25 - 1.18
09/30/25 - 0.96
Operating Margin
03/31/26 - 8.73
12/31/25 - 9.38
09/30/25 - 9.92
Net Margin
03/31/26 - -8.42
12/31/25 - -8.09
09/30/25 - -1.25
Pre-Tax Margin
03/31/26 - -7.20
12/31/25 - -6.74
09/30/25 - 0.94
Book Value
03/31/26 - 8.19
12/31/25 - 8.16
09/30/25 - 8.17
Inventory Turnover
03/31/26 - 5.55
12/31/25 - 5.61
09/30/25 - 5.75
Debt-to-Equity
03/31/26 - 0.68
12/31/25 - 0.70
09/30/25 - 0.65
Debt-to-Capital
03/31/26 - 40.34
12/31/25 - 41.30
09/30/25 - 39.51
 

Powered by Zacks Investment Research ©